Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Share News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Ark Therapeutics, Hambledon, Nighthawk ...

Tue, 08th Feb 2011 14:28

Drug developer Ark Therapeutics has sold the majority of its wound care business to Crawford Healthcare for up to £2.7m, comprising £0.77m upfront and up to £1.93m in milestone payments.The value of the gross assets being sold was put at £1,153,000 as at 30 June 2010. The losses on ordinary activities after tax attributable to the sold businesses was £428,000.Hambledon is increasing planned output from an underground mine currently being built at its Sekisovskoye operations in Kazakhstan.First ore is due to be extracted from underground in December and the extraction rate is now expected to grow to 850,000 tonnes per annum (tpa) over five years compared with the initial plan for 500,000tpa. Gold production from the underground mine alone is targeted to incrementally reach 65,000 ounces in 2014 and 110,000 ounces in 2016. Net production at oil company Nighthawk fell to 3,086 barrels of oil in the fourth quarter of 2010 from 4,092 barrels during the previous three months.It blamed the decline on more work-overs and recompletions in the period and said first quarter output will be broadly in line with December's number.Byotrol, the developer of anti microbial hygiene technologies, has extended its pact with own-label producer McBride to jointly develop and sell residual action liquid disinfectants in the European market. It is now expected that the first product will be launched in the first half of 2011. Byotrol and McBride intend to enter into full licence agreements, with UK product launches of Byotrol-based household care products expected in the third and fourth quarters of 2011. Home care operator Southern Cross Healthcare saw revenue dip in the final quarter of 2010 to £236.3m from £240.5m (restated) the year before, while the average occupancy rate on a like for like basis declined to 87.6% from 90.7% a year earlier.Adjusted earnings before interest, tax, depreciation and amortisation tumbled to £5.0m from a restated £14.4m in the corresponding period of 2009. Net debt during the quarter rose £14.1m to £21.4m. The group continues to engage with Landlords in pursuit of a restructuring of its lease terms and will provide a further update on this subject in due course.
More News
27 Apr 2023 17:35

TRADING UPDATES: Yourgene Health sees revenue above market forecasts

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
27 Apr 2023 14:15

Byotrol re-shuffles board after end of financial year

(Sharecast News) - Specialist infection prevention technology company Byotrol said in an update on Thursday that it expected its results for the financial year just ended to be in line with market expectations, subject to audit.

Read more
22 Nov 2022 14:52

Byotrol Chair John Langlands retires; appoints executive chair and CEO

(Alliance News) - Byotrol PLC on Tuesday said it appointed chief executive officer David Traynor as executive chair with immediate effect, as non-executive chair John Langlands will retire from the business.

Read more
30 Aug 2022 14:36

IN BRIEF: Byotrol swings to annual loss on lower sales, overstocking

Byotrol PLC- Manchester, England based firm - Swings to a pretax loss of GBP1.3 million for the year that ended on March 31, from a profit of GBP1.0 million the year before. Revenue plunges to GBP6.3 million from GBP11.2 million, as product sales fall 49% to GBP5.2 million from GBP10.2 million.

Read more
28 Jul 2022 20:08

TRADING UPDATES: Scottish American outperforms; Amte picks Dundee

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
11 Jul 2022 21:40

TRADING UPDATES: Byotrol anticipating positive full-year earnings

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Jul 2022 14:42

Byotrol achieves full-year market expectations

(Sharecast News) - Infection prevention technology developer Byotrol reported full-year sales of £6.3m in a trading update on Monday, consisting of £5.2m from product sales and £1.1m from intellectual property sales and royalties.

Read more
2 Mar 2022 19:27

TRADING UPDATES: Eden Research, Abingdon guide for weaker results

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
8 Dec 2021 14:46

Byotrol revenue and profit fall due to pandemic and Brexit woes

Byotrol revenue and profit fall due to pandemic and Brexit woes

Read more
8 Dec 2021 11:45

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Read more
3 Nov 2021 14:13

EXECUTIVE CHANGES: MaxCyte promotes to chair; Sanderson adds retailers

EXECUTIVE CHANGES: MaxCyte promotes to chair; Sanderson adds retailers

Read more
2 Nov 2021 15:01

EXECUTIVE CHANGES: CFOs drop like flies; ex-IG CEO to chair Scotgold

EXECUTIVE CHANGES: CFOs drop like flies; ex-IG CEO to chair Scotgold

Read more
2 Nov 2021 09:57

AIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts

AIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts

Read more
13 Oct 2021 16:10

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
1 Oct 2021 10:30

Byotrol sells American rights to antimicrobial formulation

(Sharecast News) - Byotrol said on Friday that it has completed the sale in the Americas of its US Environmental Protection Agency (EPA)-registered, long-lasting antimicrobial surface spray to its existing licensee, Integrated Resources (IRI).

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.